Clinical Benefit of 1-Year Certolizumab Pegol Treatment in MTX-Naive, Early Rheumatoid Arthritis Patients Is Maintained after Discontinuation up to 1 YearTatsuya Atsumi,Kazuhiko Yamamoto,Tsutomu Takeuchi,Hisashi Yamanaka,Naoki Ishiguro,Yoshiya Tanaka,Katsumi Eguchi,Akira Watanabe,Hideki Origasa,Toshiharu Shoji,Osamu Togo,Toshiyuki Okada,Desiree van der Heijde,Nobuyuki Miyasaka,Takao KoikeARTHRITIS & RHEUMATOLOGY（2015）引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
